SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-084293
Filing Date
2024-07-17
Accepted
2024-07-17 16:30:13
Documents
1
Period of Report
2024-07-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6305
  Complete submission text file 0000950170-24-084293.txt   7858
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address
Polvino William James (Reporting) CIK: 0001889459 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 241122585